Compounds > 3,4-dihydroxyphenylacetic acid

3,4-dihydroxyphenylacetic acid and fluoxetine

3,4-dihydroxyphenylacetic acid has been researched along with fluoxetine in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19903 (15.00)18.7374
1990's5 (25.00)18.2507
2000's6 (30.00)29.6817
2010's4 (20.00)24.3611
2020's2 (10.00)2.80

Authors

AuthorsStudies
Caccia, S; Fracasso, C; Garattini, S; Guiso, G; Sarati, S1
Guan, XM; McBride, WJ1
Fuller, RW; Perry, KW1
Sugrue, MF1
Fuller, RW; Hemrick-Luecke, SK; Snoddy, HD1
Baker, G; McGregor, A; Roberts, DC1
Amrein, R; Dingemanse, J; Gieschke, R; Guentert, T; Wallnöfer, A1
Clarke, AS; Ebert, MH; Kraemer, GW; McKinney, WT; Schmidt, DE1
Camarero, J; Colado, MI; Esteban, B; Green, AR; O'Shea, E1
Miller, GW; Rommelfanger, KS; Weinshenker, D1
Arai, A; Baba, M; Kannari, K; Shen, H; Tomiyama, M1
Emmanouil, DE; Hagihara, PT; Papadopoulou-Daifoti, Z; Quock, DG; Quock, RM1
Boggiano, MM; Castañeda, E; Chandler-Laney, PC; Maldonado, CR; Oswald, KD; Viana, JB1
Brenes, JC; Fornaguera, J1
Huang, ZL; Li, R; Qu, WM; Tu, ZC; Urade, Y; Wang, YQ; Xu, XY1
Ansorge, MS; Esposito, E; Gingrich, JA; Gray, N; Moore, H; Morelli, E; Rebello, TJ; Steele, K1
Dygalo, NN; Kalinina, TS; Shishkina, GT1
Golub, MS; Hogrefe, CE1
Di, T; Guo, J; Guo, X; Li, P; Liu, Y; Meng, Y; Qi, C; Wang, Y; Zhang, L; Zhao, J1
Altenhofen, S; Bonan, CD; da Silva, JMK; de Melo Martins, GM; Gaspary, KV; Petersen, BD; Rübensam, G; Wiprich, MT1

Trials

1 trial(s) available for 3,4-dihydroxyphenylacetic acid and fluoxetine

ArticleYear
Pharmacokinetic and pharmacodynamic interactions between fluoxetine and moclobemide in the investigation of development of the "serotonin syndrome".
    Clinical pharmacology and therapeutics, 1998, Volume: 63, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Antidepressive Agents; Benzamides; Blood Platelets; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Moclobemide; Reference Values; Selective Serotonin Reuptake Inhibitors; Syndrome

1998

Other Studies

19 other study(ies) available for 3,4-dihydroxyphenylacetic acid and fluoxetine

ArticleYear
Effects of short- and long-term administration of fluoxetine on the monoamine content of rat brain.
    Neuropharmacology, 1992, Volume: 31, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Brain; Cerebral Cortex; Corpus Striatum; Dopamine; Drug Administration Schedule; Female; Fluoxetine; Hippocampus; Homovanillic Acid; Hydroxyindoleacetic Acid; Injections, Intraperitoneal; Rats; Rats, Inbred Strains; Reference Values; Serotonin

1992
Fluoxetine increases the extracellular levels of serotonin in the nucleus accumbens.
    Brain research bulletin, 1988, Volume: 21, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Fluoxetine; Homovanillic Acid; Hydroxyindoleacetic Acid; Kinetics; Male; Nucleus Accumbens; Perfusion; Rats; Rats, Inbred Strains; Reference Values; Septal Nuclei; Serotonin

1988
Elevation of 3,4-dihydroxyphenylacetic acid concentration by L-5-hydroxytryptophan in control and fluoxetine-pretreated rats.
    The Journal of pharmacy and pharmacology, 1981, Volume: 33, Issue:6

    Topics: 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; Animals; Brain; Fluoxetine; Male; Phenylacetates; Propylamines; Rats; Serotonin; Synapses

1981
The inability of chronic fluoxetine to potentiate a serotonin mediated effect.
    Communications in psychopharmacology, 1980, Volume: 4, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Drug Interactions; Fluoxetine; Haloperidol; Homovanillic Acid; Male; Propylamines; Rats; Serotonin

1980
Fluoxetine at anorectic doses does not have properties of a dopamine uptake inhibitor.
    Journal of neural transmission. General section, 1994, Volume: 96, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Appetite Depressants; Brain Chemistry; Dopamine; Dopamine Uptake Inhibitors; Fluoxetine; Homovanillic Acid; Injections, Intraventricular; Male; Mazindol; Neostriatum; Oxidopamine; Rats; Rats, Sprague-Dawley

1994
Effect of 6-hydroxydopamine lesions of the amygdala on intravenous cocaine self-administration under a progressive ratio schedule of reinforcement.
    Brain research, 1994, May-23, Volume: 646, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; 5,7-Dihydroxytryptamine; Amygdala; Analysis of Variance; Animals; Behavior, Animal; Benzazepines; Brain; Chlordiazepoxide; Cocaine; Desipramine; Dopamine; Estrus; Female; Fluoxetine; Ibotenic Acid; Injections, Intravenous; Male; Organ Specificity; Oxidopamine; Rats; Rats, Wistar; Self Administration; Time Factors; Tryptophan

1994
Biogenic amine activity in response to fluoxetine and desipramine in differentially reared rhesus monkeys.
    Biological psychiatry, 1999, Jul-15, Volume: 46, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animal Husbandry; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety, Separation; Behavior, Animal; Binding, Competitive; Biogenic Amines; Desipramine; Fluoxetine; Homovanillic Acid; Hydroxyindoleacetic Acid; Macaca mulatta; Methoxyhydroxyphenylglycol; Random Allocation; Social Environment; Time Factors

1999
Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain.
    Neuropharmacology, 2001, Volume: 40, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Body Temperature; Brain Chemistry; Dopamine; Dopamine Uptake Inhibitors; Fluoxetine; Homovanillic Acid; Male; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents

2001
Reduced MPTP toxicity in noradrenaline transporter knockout mice.
    Journal of neurochemistry, 2004, Volume: 91, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Blotting, Western; Brain Chemistry; Chromatography, High Pressure Liquid; Dopamine; Dopamine Plasma Membrane Transport Proteins; Drug Interactions; Electrochemistry; Fluoxetine; Homovanillic Acid; Immunohistochemistry; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; MPTP Poisoning; Nerve Tissue Proteins; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Symporters; Time Factors; Tyrosine 3-Monooxygenase; Vesicular Biogenic Amine Transport Proteins

2004
Reuptake of L-DOPA-derived extracellular dopamine in the striatum with dopaminergic denervation via serotonin transporters.
    Neuroscience letters, 2006, Jul-10, Volume: 402, Issue:1-2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Extracellular Fluid; Fluoxetine; Homovanillic Acid; Levodopa; Male; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins

2006
A study of the role of serotonin in the anxiolytic effect of nitrous oxide in rodents.
    Pharmacology, biochemistry, and behavior, 2006, Volume: 84, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Anxiety Agents; Cinanserin; Corpus Striatum; Dopamine; Fluoxetine; Frontal Lobe; Hippocampus; Hydroxyindoleacetic Acid; Hypothalamus; Indazoles; Male; Mice; Nitrous Oxide; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT2; Receptors, Serotonin, 5-HT3; Selective Serotonin Reuptake Inhibitors; Serotonin; Tropanes

2006
A history of human-like dieting alters serotonergic control of feeding and neurochemical balance in a rat model of binge-eating.
    The International journal of eating disorders, 2007, Volume: 40, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antidepressive Agents, Second-Generation; Brain; Bulimia; Diet, Reducing; Disease Models, Animal; Dopamine; Energy Intake; Feeding Behavior; Female; Fluoxetine; Humans; Hydroxyindoleacetic Acid; Hypothalamus; Injections, Intraperitoneal; Norepinephrine; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Serotonin; Tegmentum Mesencephali

2007
The effect of chronic fluoxetine on social isolation-induced changes on sucrose consumption, immobility behavior, and on serotonin and dopamine function in hippocampus and ventral striatum.
    Behavioural brain research, 2009, Mar-02, Volume: 198, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Basal Ganglia; Behavior, Animal; Chromatography, High Pressure Liquid; Dopamine; Eating; Fluoxetine; Hippocampus; Immobility Response, Tonic; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Social Isolation; Sucrose; Swimming; Time Factors

2009
Acute administration of fluoxetine normalizes rapid eye movement sleep abnormality, but not depressive behaviors in olfactory bulbectomized rats.
    Journal of neurochemistry, 2012, Volume: 120, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Biogenic Monoamines; Chromatography, High Pressure Liquid; Depression; Disease Models, Animal; Electrochemistry; Electroencephalography; Electromyography; Exploratory Behavior; Fluoxetine; Hydroxyindoleacetic Acid; Male; Olfactory Bulb; Rats; Rats, Sprague-Dawley; Sleep, REM; Swimming

2012
Chronic 5-HT transporter blockade reduces DA signaling to elicit basal ganglia dysfunction.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2011, Nov-02, Volume: 31, Issue:44

    Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Animals; Animals, Newborn; Basal Ganglia; Cell Count; Chromatography, High Pressure Liquid; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Exploratory Behavior; Fluoxetine; Homovanillic Acid; Levodopa; Male; Mice; Mice, Transgenic; Movement Disorders; Psychomotor Performance; Random Allocation; Rotarod Performance Test; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Signal Transduction; Substantia Nigra; Ventral Tegmental Area

2011
Effects of swim stress and fluoxetine on 5-HT1A receptor gene expression and monoamine metabolism in the rat brain regions.
    Cellular and molecular neurobiology, 2012, Volume: 32, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Neurons; Animals; Biogenic Monoamines; Brain; Dopaminergic Neurons; Fluoxetine; Gene Expression Regulation; Immobilization; Male; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; RNA, Messenger; Stress, Physiological; Swimming

2012
Fluoxetine: juvenile pharmacokinetics in a nonhuman primate model.
    Psychopharmacology, 2014, Volume: 231, Issue:20

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dose-Response Relationship, Drug; Female; Fluoxetine; Homovanillic Acid; Hydroxyindoleacetic Acid; Macaca mulatta; Male; Models, Animal; Selective Serotonin Reuptake Inhibitors; Serotonin

2014
Depressive-like behaviors in mice with Imiquimod-induced psoriasis.
    International immunopharmacology, 2020, Volume: 89, Issue:Pt B

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Brain; Cytokines; Depression; Disease Models, Animal; Epinephrine; Exploratory Behavior; Fluoxetine; Food Preferences; gamma-Aminobutyric Acid; Imiquimod; Male; Mice, Inbred BALB C; Neurotransmitter Agents; Norepinephrine; Open Field Test; Psoriasis; Serotonin; Skin

2020
Physical exercise prevents behavioral alterations in a reserpine-treated zebrafish: A putative depression model.
    Pharmacology, biochemistry, and behavior, 2022, Volume: 220

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antidepressive Agents; Behavior, Animal; COVID-19; Depression; Depressive Disorder, Major; Dopamine; Exercise; Fluoxetine; Humans; Pandemics; Reserpine; Serotonin; Zebrafish

2022